SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-058507
Filing Date
2018-11-09
Accepted
2018-11-09 08:00:22
Documents
6
Period of Report
2018-12-17
Effectiveness Date
2018-11-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv505627-def14a.htm DEF 14A 415661
2 GRAPHIC sig_jcook.jpg GRAPHIC 12262
3 GRAPHIC tv505568_pc1.jpg GRAPHIC 138515
4 GRAPHIC tv505568_pc2.jpg GRAPHIC 153497
5 GRAPHIC tv505568_pc3.jpg GRAPHIC 255213
6 GRAPHIC tv505568_pc4.jpg GRAPHIC 155986
  Complete submission text file 0001144204-18-058507.txt   1366282
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 181171413
SIC: 2836 Biological Products, (No Diagnostic Substances)